医疗器械公司波士顿科学(BSX.US)涨超4.4%，报104.36美元。 消息面上，波士顿科学第三季度销售额同比增长20%至50.7亿美元，超出华尔街分析师预期的49.7亿美元。其中，心血管部门的销售额同比增长22%至33.4亿美元，高于预期的32.7亿美元。期内调整后每股收益为75美分，高于预期的71美分。公司上调全年调整后每股收益指引至3.02至3.04美元，超过分析师预期的2.98美元。(格隆汇)
医疗器械公司波士顿科学(BSX.US)涨超4.4%，报104.36美元。 消息面上，波士顿科学第三季度销售额同比增长20%至50.7亿美元，超出华尔街分析师预期的49.7亿美元。其中，心血管部门的销售额同比增长22%至33.4亿美元，高于预期的32.7亿美元。期内调整后每股收益为75美分，高于预期的71美分。公司上调全年调整后每股收益指引至3.02至3.04美元，超过分析师预期的2.98美元。(格隆汇)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.